ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 392 filers reported holding ENCOMPASS HEALTH CORP in Q2 2019. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,316 | -99.6% | 24,328 | +220.6% | 0.00% | – |
| Q3 2022 | $343,000 | -94.5% | 7,588 | -91.3% | 0.00% | -100.0% |
| Q1 2022 | $6,218,000 | +3009.0% | 87,453 | +2748.6% | 0.01% | – |
| Q4 2021 | $200,000 | +88.7% | 3,070 | +130.1% | 0.00% | – |
| Q3 2021 | $106,000 | -32.9% | 1,334 | -34.1% | 0.00% | – |
| Q2 2021 | $158,000 | -32.5% | 2,025 | -43.9% | 0.00% | – |
| Q3 2020 | $234,000 | +162.9% | 3,610 | +148.8% | 0.00% | – |
| Q2 2020 | $89,000 | -92.0% | 1,451 | -92.4% | 0.00% | -100.0% |
| Q1 2019 | $1,113,000 | +8.2% | 19,060 | +14.2% | 0.00% | 0.0% |
| Q4 2018 | $1,029,000 | +244.1% | 16,689 | +334.9% | 0.00% | +200.0% |
| Q3 2018 | $299,000 | – | 3,837 | +76640.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 5 | -99.8% | 0.00% | -100.0% |
| Q1 2018 | $167,000 | – | 2,929 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Copeland Capital Management, LLC | 569,048 | $28,117,000 | 1.78% |
| Kalos Management, Inc. | 76,118 | $3,761,000 | 1.77% |
| Bridge City Capital, LLC | 30,231 | $1,494,000 | 1.08% |
| DALTON GREINER HARTMAN MAHER & CO | 331,823 | $16,395,000 | 0.86% |
| Horrell Capital Management, Inc. | 28,641 | $1,415,000 | 0.74% |
| Polianta Ltd | 26,600 | $1,314,000 | 0.43% |
| GLOBEFLEX CAPITAL L P | 30,177 | $1,491,000 | 0.42% |
| CARILLON TOWER ADVISERS, INC. | 768,748 | $37,984,000 | 0.40% |
| EAGLE ASSET MANAGEMENT INC | 1,070,271 | $53,001,000 | 0.29% |
| S. R. Schill & Associates | 8,108 | $401,000 | 0.25% |